Health Systems in Transition - Hungary - World Health Organization ...
Health Systems in Transition - Hungary - World Health Organization ...
Health Systems in Transition - Hungary - World Health Organization ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Health</strong> systems <strong>in</strong> transition <strong>Hungary</strong> 149<br />
The government that took office <strong>in</strong> 2010 has returned to the orig<strong>in</strong>al, ethical<br />
model of corporate responsibility. In June 2010 the licens<strong>in</strong>g of new pharmacies<br />
was suspended and further mergers were banned (2010/9). Moreover, <strong>in</strong><br />
December 2010 a new act was passed endors<strong>in</strong>g the gradual reacquisition<br />
of ownership by pharmacists: Act CLXXIII of 2010 on the Amendment of<br />
Certa<strong>in</strong> <strong>Health</strong> Care Related Acts br<strong>in</strong>gs the operation of pharmacies under the<br />
personal responsibility of pharmacists <strong>in</strong> order to enable them to contribute to<br />
efficient therapies and prevention programmes and to support healthy lifestyles<br />
(Articles 77 and 83). The m<strong>in</strong>imum share of pharmacists’ ownership <strong>in</strong> already<br />
function<strong>in</strong>g pharmacies must now reach 25% by 2014 and 50% by 2017 (Article<br />
84). Actors <strong>in</strong> the pharmaceutical supply cha<strong>in</strong> are not allowed to own newly<br />
established pharmacies, and mergers are banned for cha<strong>in</strong>s that consist of more<br />
than four pharmacies (Article 84). As for the pharmacies already owned by<br />
wholesalers, the shares must be adapted to the stipulated limits, but currently<br />
operat<strong>in</strong>g pharmacy cha<strong>in</strong>s may be ma<strong>in</strong>ta<strong>in</strong>ed. As of May 2011, no offshore<br />
company will be allowed to hold shares <strong>in</strong> pharmacies (Article 87).<br />
The demographic and geographical criteria for establish<strong>in</strong>g new pharmacies<br />
have also been changed. A community pharmacy can only be established<br />
based on national tenders. In the case of municipalities with less than 50 000<br />
<strong>in</strong>habitants, the m<strong>in</strong>imum demographic criterion is 4500 persons per pharmacy<br />
(<strong>in</strong>clud<strong>in</strong>g the new one) and the m<strong>in</strong>imal geographical distance between<br />
pharmacies is set at 300 metres. In the case of bigger towns, the numbers<br />
are 4000 persons and 250 metres. The restrictions do not apply if the given<br />
municipality has no established pharmacy (Article 69). Dur<strong>in</strong>g the evaluation<br />
of tenders, priority is given to pharmacies that <strong>in</strong>tend to provide additional<br />
services, such as longer open<strong>in</strong>g hours, out-of-hours services, runn<strong>in</strong>g a branch<br />
pharmacy or provid<strong>in</strong>g home delivery (Article 68). These changes aim to ensure<br />
that new pharmacies meet local needs and contribute additional services. The<br />
new provisions also regulate pharmacies’ promotional activities, prohibit<strong>in</strong>g<br />
such activities for reimbursed medic<strong>in</strong>es and restrict<strong>in</strong>g them to the provision<br />
of health care services <strong>in</strong> the case of non-reimbursed drugs (Article 59).<br />
In 2009 a total of 5301 pharmacists and 7536 pharmaceutical assistants<br />
worked <strong>in</strong> community pharmacies, whereas another 430 pharmacists and 790<br />
assistants worked <strong>in</strong> hospital pharmacies (HCSO, 2010f). Accord<strong>in</strong>g to the<br />
concept of pharmaceutical care <strong>in</strong>troduced <strong>in</strong> 2009 (2008/9), pharmacists are<br />
expected to provide health <strong>in</strong>formation and prevention activities, supervise<br />
and monitor drug treatment, work to m<strong>in</strong>imize side effects and avoid harmful